Articles
Hypertension
h 
Renovascular hypertension in blacks
(Jan 96 AJH)
h
Reversal of sodium pump inhibitor induced vascular smooth muscle
contraction with digibind
(Jan 96 AJH)
h
Antihypertensive agents affect serum lipid levels
(Jan 96 AIM)
h
Impaired exercise tolerance in hypertensive patients
(Jan 96 AIM)
h
Persistent elevation of plasma insulin levels is associated with
increased cardiovascular risk in children and young adults
(Jan 96 CIRC)
h
Plasma adrenomedullin concentrations in essential hypertension
(Jan 96 HYP)
h
Polymorphism of the glycogen synthase gene in hypertensive and
normotensive subjects
(Jan 96 HYP)
h
Hypertensive urgencies and emergencies: prevalence and clinical
presentation
(Jan 96 HYP)
h 
Sympathetic nerve activity and insulin in obese normotensive
and hypertensive men
(Feb 96 HYP)
h
Endogenous renal 11ß-hydroxysteroid dehydrogenase inhibitory
factors in essential hypertension
(Feb 96 HYP)
h
Increased vasoconstrictor sensitivity to glucocorticoids in essential
hypertension
(Feb 96 HYP)
h 
Chymase dependent angiotensin II forming system in humans
(Mar 96 AJH)
h
Acute aerobic exercise reduces ambulatory blood pressure in
borderline hypertensive men
(Mar 96 AJH)
h
Changes in frequency of orthostatic hypotension in elderly
hypertensive patients under medications
(Mar 96 AJH)
Dialysis, Chronic Renal Failure
d
Falsely elevated serum vancomycin concentration in hemodialysis
patients
(Jan 96 AJKD)
d
Spinal epidural abscess in hemodialysis patients: report of three
cases and review of the literature
(Jan 96 AJKD)
d
Clarithromycin-associated visual hallucinations in a patient with
chronic renal failure on CAPD
(Jan 96 AJKD)
d
Four-year experience with swan neck presternal peritoneal dialysis
catheter
(Jan 96 AJKD)
d
Androgen versus erythropoeitin for the treatment of anemia in
hemodialyzed patients: a prospective study
(Jan 96 JASN)
d
Magnesium carbonate as a phosphorus binder: A prospective,
controlled, crossover study
(Jan 96 KI)
d
The set point of calcium and the reduction of parathyroid
hormone in dialysis patients
(Jan 96 KI)
d
High dose B vitamin treatment of hyperhomocysteinemia in
dialysis patients
(Jan 96 KI)
d
Determination of residual renal function with iohexol clearance
in hemodialysis patients
(Jan 96 KI)
d
Low dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-
intoxicated haemodialysis patients using two drug administration schedules
(Jan 96 NDT)
d
Helicobacter pylori-specific IgG in chronic haemodialysis
patients: Relationship of hypergastrinaemia to positive serology
(Jan 96 NDT)
d
Hemolytic reactions mechanically induced by kinked hemodialysis tubing
(Feb 96 AJKD)
d
The benefits and side effects of ramped hypertonic sodium dialysis
(Feb 96 JASN)
d
The intensity of hemodialysis and the response to
erythropoietin in patients with end-stage renal disease
(Feb 96 NEJM)
d
Lithium poisoning treated by high-performance continuous
arteriovenous and venovenous hemodiafiltration
(Mar 96 AJKD)
d
Effect of increasing dialysis dose on serum albumin and
mortality in hemodialysis
(Mar 96 AJKD)
d
Clinical experience with a new recombinant hepatitis-B vaccine in
previous non-responders with chronic renal insufficiency
(Mar 96 CN)
d
Low dose megestrol (Megace) increases serum albumin in
malnourished dialysis patients
(Mar 96 IJAO)
d
Calcitriol and the parathyroid hormone -- ionized calcium
curve: a comparison of methodologic approaches
(Mar 96 JASN)
d
Pharmacokinetics and efficiency of pulse oral versus intravenous
calcitriol in hemodialysis patients
(Mar 96 JASN)
d
Long-term treatment of growth-retarded children with chronic renal
insufficiency with recombinant human growth hormone
(Mar 96 KI)
d
Citrate compared to low molecular weight heparin
anticoagulation in chronic hemodialysis patients
(Mar 96 KI)
d
An elevated ratio of measured to predicted creatinine production in
CAPD patients is not a sensitive predictor of non-compliance with the
dialysis prescription
(Mar 96 PDI)
d
The effect of dietary protein restriction on the progression of
diabetic and non-diabetic renal diseases: a meta-analysis
(Mar 96 AIM)
Clinical Nephrology
c
Renal allograft and patient outcome after transplantation: pancreas
-kidney versus kidney-alone transplants in type I diabetics vs
kidney-alone transplants in nondiabetics
(Jan 96 AJKD)
c
Serum albumin and mortality after renal transplantation
(Jan 96 AJKD)
c
Evaluation of urine acidification by urine anion gap and
urine osmolal gap in chronic metabolic acidosis
(Jan 96 AJKD)
c
Analgesics and the kidney: Summary and recommendations to the
Scientific Advisory Board of the NKF from an Ad Hoc Committee of the NKF
(Jan 96 AJKD)
c
Prognostic markers in patients with antineutrophil cytoplasmic
antibody-associated polyangiitis and glomerulonephritis
(Jan 96 JASN)
c
D-lactic acidosis: Turning sugar into acids in the gastrointestinal
tract
(Jan 96 KI)
c
A prospective study of the natural history of idiopathic non-proteinuric
hematuria
(Jan 96 KI)
c
Bilateral nephrectomy stopped disease progression in plasma-resistant
hemolytic uremic syndrome with neurologic signs and coma
(Jan 96 KI)
c
Management of lupus nephritis
(Jan 96 KI)
c
Hypercalcemia with lymphoedema
(Jan 96 LAN)
c
Preliminary description of focal segmental glomerulosclerosis in
patients with renovascular disease
(Jan 96 LAN)
c
Rolaids-yogurt syndrome: A 1990s version of milk-alkali
syndrome
(Feb 96 AJKD)
c
Gallium 67 scintigraphy as a predictor of renal prognosis in primary
IgA nephropathy
(Feb 96 AJKD)
c
Hyperkalemia in hospitalized patients treated with trimethoprim-
sulfamethoxazole
(Feb 96 AIM)
c
Long-term outcome in SLE membranous glomerulonephritis
(Feb 96 JASN)
c
High incidence of common bile duct dilatation in autosomal dominant
polycystic kidney disease patients
(Mar 96 AJKD)
c
Nephrogenic diabetes insipidus and renal tubular acidosis
secondary to foscarnet therapy
(Mar 96 AJKD)
c
Cyclophosphamide-induced cystitis and bladder cancer in
patients with Wegener granulomatosis
(Mar 96 AIM)
c
Safety of pamidronate in patients with renal failure and
hypercalcemia
(Mar 96 CN)
c
Prerenal azotemia: differentiation or hyperureagenesis from renal
hypoperfusion using urea nitrogen data
(Mar 96 IJAO)
c
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times:
Association with improvement in long-term survival
(Mar 96 KI)
c
Monitoring urinary levels of chemotactic and activating factor
reflects disease activity of lupus nephritis
(Mar 96 KI)
c
Renal function on and off lithium in patients treated with
lithium for 15 years or more. A controlled, prospective lithium withdrawal
study.
(Mar 96 NDT)
c
Plasma total versus bone alkaline phosphatase as markers of bone
turnover in hemodialysis patients
(Mar 96 JASN)
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.